8-K
filed November 14, 2025, 6:59 PM ET
ticker IDAI
CIK 0001718939
earnings
confidence high
sentiment positive
materiality 0.70
T Stamp Q3 revenue up 71% YoY to $0.87M; operating expenses down 17%
T Stamp Inc
2025-Q3 EPS reported
-$2.28
revenue$2,230,629
- Net recognized revenue of $0.87M for Q3 2025, up 71% from $0.51M in Q3 2024.
- Nine-month revenue $2.23M, up 41% YoY; deferred revenue $0.33M as of Sep 30, 2025.
- Total operating expenses down 17% in Q3 and 19% in 9 months to $2.64M and $7.85M.
- Basic net loss per share improved to $0.72 (Q3) and $2.28 (9 months) vs $1.06 and $7.33.
- S&P 500 bank contract extended to May 2031 with minimum gross revenue >$12.7M.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001718939-25-000160
- form_type
- 8-K
- ticker
- IDAI
- cik
- 0001718939
- company_name
- T Stamp Inc
- filed_at
- 2025-11-14T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:40.246873+00:00
- generated_at
- 2026-05-16T19:53:01.118329+00:00
- sec_items
- ["2.02", "9.01"]
- event_type
- earnings
- sentiment
- positive
- materiality_score
- 0.7
- calibrated_materiality_score
- 0.7
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001718939-25-000160
- json_url
- https://secwatch.observer/filing/0001718939-25-000160.json
- markdown_url
- https://secwatch.observer/filing/0001718939-25-000160.md
- text_url
- https://secwatch.observer/filing/0001718939-25-000160.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1718939/000171893925000160/0001718939-25-000160-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1718939/000171893925000160/idai-20251114.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
GTLB
GitLab Q1 revenue $264M (+23% YoY); plans 14% workforce cut, $30-35M charges
Gitlab Inc.
June 2, 2026, 4:17 PM ET
earnings
Items 2.02, 2.05, 7.01, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
PETS
PetMed Q4 sales fall 15.6% to $42.8M; FY net loss widens to $57.3M on goodwill impairment
PETMED EXPRESS INC
June 2, 2026, 4:15 PM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
SPWH
Sportsman's Warehouse Q1 net sales up 2.8% to $256.1M; same-store sales +2.1%; net loss $21.8M
SPORTSMAN'S WAREHOUSE HOLDINGS, INC.
June 2, 2026, 4:10 PM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
ULTA
Ulta Q1 net sales +11.1% to $3.16B, comps +5.3%; FY EPS guidance raised to $28.36-$28.80
Ulta Beauty, Inc.
June 2, 2026, 4:06 PM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
YEXT
Yext Q1 FY27: Adj EBITDA margin 25%, ARR $440.8M; boosts buyback by $100M
Yext, Inc.
June 2, 2026, 4:05 PM ET
earnings
Items 2.02, 8.01, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
IVF
INVO Fertility FY2025 revenue $6.84M (+5% YoY); net loss improves to $(5.3)M
INVO Fertility, Inc.
June 2, 2026, 8:40 AM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
POLA
Polar Power Q1 net loss narrows 86% to $178K; gross margin expands to 65.7%
Polar Power, Inc.
June 2, 2026, 8:30 AM ET
earnings
Items 2.02, 7.01, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
CTRN
Citi Trends Q1 sales up 14.4% to $230.9M; adjusted EBITDA doubles to $13.9M
Citi Trends Inc
June 2, 2026, 6:58 AM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.